---
document_datetime: 2025-11-23 08:01:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zoledronic-acid-teva-generics.html
document_name: zoledronic-acid-teva-generics.html
version: success
processing_time: 0.1083762
conversion_datetime: 2025-12-24 18:22:46.687384
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zoledronic acid Teva Generics

[RSS](/en/individual-human-medicine.xml/66450)

##### Withdrawn

This medicine's authorisation has been withdrawn

zoledronic acid

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Zoledronic acid Teva Generics](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 July 2015 the European Commission withdrew the marketing authorisation for Zoledronic acid Teva Generics (zoledronic acid) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva Generics B.V, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Zoledronic acid Teva Generics was granted marketing authorisation in the EU on 27 March 2014 for the treatment of osteoporosis and Paget's disease of the bone. The marketing authorisation was initially valid for a 5-year period.

Zoledronic acid Teva Generics is a generic medicine of Aclasta. Zoledronic acid Teva Generics was a duplicate application to Zoledronic acid Teva Pharma, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Zoledronic acid Teva Pharma.

The European Public Assessment Report (EPAR) for Zoledronic acid Teva Generics is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Zoledronic acid Teva Generics : EPAR - Summary for the public

Reference Number: EMA/60227/2014

English (EN) (541.61 KB - PDF)

**First published:** 30/04/2014

**Last updated:** 08/08/2016

[View](/en/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-131)

български (BG) (627.31 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/bg/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_bg.pdf)

español (ES) (564.04 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/es/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_es.pdf)

čeština (CS) (604.81 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/cs/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_cs.pdf)

dansk (DA) (542.77 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/da/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_da.pdf)

Deutsch (DE) (543.14 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/de/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_de.pdf)

eesti keel (ET) (540.92 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/et/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_et.pdf)

ελληνικά (EL) (643.63 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/el/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_el.pdf)

français (FR) (543.03 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fr/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_fr.pdf)

hrvatski (HR) (562.2 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hr/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_hr.pdf)

italiano (IT) (539.95 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/it/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_it.pdf)

latviešu valoda (LV) (621.43 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lv/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (565.97 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lt/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_lt.pdf)

magyar (HU) (599.83 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hu/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_hu.pdf)

Malti (MT) (603.28 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/mt/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_mt.pdf)

Nederlands (NL) (541.26 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/nl/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_nl.pdf)

polski (PL) (605.31 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pl/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_pl.pdf)

português (PT) (543.04 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pt/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_pt.pdf)

română (RO) (566.14 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/ro/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_ro.pdf)

slovenčina (SK) (604.86 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sk/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_sk.pdf)

slovenščina (SL) (596.41 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sl/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_sl.pdf)

Suomi (FI) (539.97 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fi/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_fi.pdf)

svenska (SV) (540.78 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sv/documents/overview/zoledronic-acid-teva-generics-epar-summary-public_sv.pdf)

Zoledronic acid Teva Generics : EPAR - Risk-management-plan summary

Reference Number: EMA/77822/2014

English (EN) (538.9 KB - PDF)

**First published:** 30/04/2014

**Last updated:** 08/08/2016

[View](/en/documents/rmp-summary/zoledronic-acid-teva-generics-epar-risk-management-plan-summary_en.pdf)

## Product information

Zoledronic acid Teva Generics : EPAR - Product Information

English (EN) (1.12 MB - PDF)

**First published:** 30/04/2014

**Last updated:** 08/08/2016

[View](/en/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-883)

български (BG) (2.6 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/bg/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_bg.pdf)

español (ES) (1.14 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/es/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_es.pdf)

čeština (CS) (2.09 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/cs/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_cs.pdf)

dansk (DA) (1.11 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/da/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_da.pdf)

Deutsch (DE) (1.22 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/de/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_de.pdf)

eesti keel (ET) (1.16 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/et/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_et.pdf)

ελληνικά (EL) (2.67 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/el/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_el.pdf)

français (FR) (1.13 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fr/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_fr.pdf)

hrvatski (HR) (1.22 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hr/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_hr.pdf)

íslenska (IS) (1.18 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/is/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_is.pdf)

italiano (IT) (1.19 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/it/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_it.pdf)

latviešu valoda (LV) (2.21 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lv/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.31 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lt/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_lt.pdf)

magyar (HU) (2.15 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hu/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_hu.pdf)

Malti (MT) (2.2 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/mt/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_mt.pdf)

Nederlands (NL) (1.02 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/nl/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_nl.pdf)

norsk (NO) (1.09 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/no/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_no.pdf)

polski (PL) (2.2 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pl/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_pl.pdf)

português (PT) (1.15 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pt/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_pt.pdf)

română (RO) (1.29 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/ro/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_ro.pdf)

slovenčina (SK) (2.17 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sk/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_sk.pdf)

slovenščina (SL) (2.23 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sl/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_sl.pdf)

Suomi (FI) (1.11 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fi/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_fi.pdf)

svenska (SV) (1.07 MB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sv/documents/product-information/zoledronic-acid-teva-generics-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0002 13/07/2015

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Zoledronic acid Teva Generics : EPAR - All Authorised presentations

English (EN) (480.97 KB - PDF)

**First published:** 30/04/2014

**Last updated:** 08/08/2016

[View](/en/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-302)

български (BG) (527.49 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/bg/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_bg.pdf)

español (ES) (476.03 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/es/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_es.pdf)

čeština (CS) (513.46 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/cs/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (491.94 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/da/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (491.48 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/de/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (481.5 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/et/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (520.56 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/el/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_el.pdf)

français (FR) (481.64 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fr/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (497.75 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hr/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (481.94 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/is/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_is.pdf)

italiano (IT) (481.73 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/it/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (514.58 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lv/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (499.05 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/lt/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (513.73 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/hu/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (512.19 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/mt/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (482.01 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/nl/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (481.54 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/no/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_no.pdf)

polski (PL) (509.61 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pl/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_pl.pdf)

português (PT) (479.73 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/pt/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_pt.pdf)

română (RO) (494.58 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/ro/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (504.57 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sk/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (503.36 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sl/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (470.36 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/fi/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (476.21 KB - PDF)

**First published:**

30/04/2014

**Last updated:**

08/08/2016

[View](/sv/documents/all-authorised-presentations/zoledronic-acid-teva-generics-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Zoledronic acid Teva Generics Active substance zoledronic acid monohydrate International non-proprietary name (INN) or common name zoledronic acid Therapeutic area (MeSH)

- Osteoporosis
- Osteitis Deformans

Anatomical therapeutic chemical (ATC) code M05BA08

### Pharmacotherapeutic group

Bisphosphonates

### Therapeutic indication

Treatment of osteoporosis

- in post-menopausal women
- in adult men

at increased risk of fracture, including those with recent low-trauma hip fracture.

Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy

- in post-menopausal women
- in adult men

at increased risk of fracture.

Treatment of Paget's disease of the bone in adults.

## Authorisation details

EMA product number EMEA/H/C/002805

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Teva Generics B.V

Computerweg 10

Opinion adopted 23/01/2014 Marketing authorisation issued 27/03/2014 Withdrawal of marketing authorisation 13/07/2015 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Zoledronic acid Teva Generics : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (533.21 KB - PDF)

**First published:** 06/10/2014

**Last updated:** 08/08/2016

[View](/en/documents/procedural-steps-after/zoledronic-acid-teva-generics-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Zoledronic acid Teva Generics : EPAR - Public assessment report

Adopted

Reference Number: EMA/179093/2014

English (EN) (773.29 KB - PDF)

**First published:** 30/04/2014

**Last updated:** 08/08/2016

[View](/en/documents/assessment-report/zoledronic-acid-teva-generics-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Zoledronic acid Teva Generics

Adopted

Reference Number: EMA/CHMP/25433/2014

English (EN) (66.7 KB - PDF)

**First published:** 24/01/2014

**Last updated:** 24/01/2014

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-zoledronic-acid-teva-generics_en.pdf)

#### News on Zoledronic acid Teva Generics

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 January 2014](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-january-2014) 24/01/2014

**This page was last updated on** 08/08/2016

## Share this page

[Back to top](#main-content)